Novocure

📍 Root, Switzerland🗓 Founded 2000👥 1,236 employees💰 Last funded Aug 2009
Medical Equipment Manufacturing🌐 novocure.com
Website LinkedIn
We are a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of our innovative therapy, Tumor Treating Fields. Our commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma. We have ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and gastric cancer. Headquartered in Switzerland, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, Novocure has offices in Germany, Jersey, Japan and Israel.
3
Total investors
0
Early stage
1
Mid stage
2
Late stage
2000
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Investor activity2004–2009 · investors recorded per year
200412006120091
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Novocure?
Novocure has 3 investors on record on gritt.io, 1 mid-stage and 2 late-stage investors.
When did Novocure last raise funding?
The most recent investment in Novocure recorded on gritt.io was in August 2009.
When was Novocure founded?
Novocure was founded in 2000.
What industry is Novocure in?
Novocure operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Novocure based?
Novocure is headquartered in Root, Switzerland.